Summary
Genomic hybridization analysis has been used to investigate allelic frequencies of the genes coding for the four major apoproteins of high density lipoprotein (HDL); apoproteins AI, AII, CII and CIII, in a group of Caucasian subjects with primary gout. An uncommon allelic variant of the apoprotein CIII gene (the S2 allele) was significantly more common among the patients with gout (9/48, 19%) than among normouricaemic controls who were either randomly selected (1/41, 2%, P=0.03) or normotriglyceidaemic (0/33, 0%, P=0.013). Approximately 46% (22/48) of the subjects with gout were hypertriglyceridaemic (with a serum triglyceride >2.1 mmol/l). Of the 22 patients in this subgroup, 5 (23%) had the uncommon S1S2 genotype, which was also a significantly greater proportion than among the normotriglyceridaemic controls (P=0.015). These data suggest that the hypertriglyceridaemia associated with primary gout may have a genetic basis. In contrast, we found no differences in the frequencies of restriction fragment length polymorphisms of the genes for apoproteins AI, AII and CII.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barlow KA (1968) Hyperlipidaemia in primary gout. Metabolism 17: 289–294
Berkowitz D (1964) Blood lipid and uric acid interrelationships. JAMA 190:856–858
Bluestone R, Lewis B, Mervant J (1971) Hyperlipidaemia in gout. Ann Rheum Dis 30:134–137
Darlington LG, Scott JT (1972) Plasma lipid levels in gout. Ann Rheum Dis 31:487–489
Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ, Motulsky AG (1987) Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harbor Symp Quant Biol 51:403–409
Feldman EB, Wallace SL (1964) Hypertriglyceridaemia in gout. Circulation 29:508–513
Ferns GAA, Lanham J, Stocks J, Ritchie C, Katz J, Galton DJ (1985a) The measurement of high density lipoprotein subfractions in patients with primary gout using a simple precipitation method. Ann Clin Biochem 22:526–532
Ferns GAA, Stocks J, Ritchie C, Galton DJ (1985b) Genetic polymorphisms of apolipoprotein CIII and insulin in survivors of myocardial infarction. Lancet II:300–303
Ferns GAA, Robinson D, Stocks J, Bevan E, Williams P, Galton DJ (1986) HDL cholesterol subfractions in healthy males: relation to serum triglyceride levels and age. Ann Clin Biochem 23:504–508
Gibson T, Grahame R (1974) Gout and hyperlipidaemia. Ann Rheum Dis 33:298–303
Gidez LI, Miller GJ, Burstein M, Eder HA (1982) Separation and quantitation of subclasses of human high density lipoproteins by a simple precipitation method. J Lipid Res 23:1206–1223
Harris-Jones JN (1957) Hyperuricaemia and essential hypercholesterolaemia. Lancet I:857
Herbert PN, Assmann G, Gotto AM, Fredrickson DS (1983) Familial lipoprotein deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 589–621
Jowett NI, Rees A, Williams L, Stocks J, Vella M, Hitman G, Katz J, Galton DJ (1984) Insulin and apolipoprotein AI/CIII gene polymorphisms relating to hypertriglyceridaemia and diabetes mellitus. Diabetologia 27:180–183
Karathanasis SK (1985) Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII and AIV genes. Proc Natl Acad Sci USA 82:6374–6378
Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW, Rary JM (1977) Analysis of human Y chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245–1249
Macfarlane DG, Midwinter CA, Dieppe PA, Bolton CH, Hartog M (1985) Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout. Ann Rheum Dis 44: 390–394
Martini S, Baggio G, Baroni L (1984) Evaluation of HDL2 and HDL3 cholesterol by a precipitation procedure in normal and different hyperlipidaemic phenotypes. Clin Chim Acta 137:291–298
Myklebost O, Williamson R, Markham AF, Myklebost SR, Rogers J, Woods DE, Humphries S (1984) The isolation and characterization of cDNA clones for human apolipoprotein CII. J Biol Chem 259:4401–4404
Naito HK, MacKenzie AH (1979) Secondary hypertriglyceridaemia and hyperlipoproteinaemia in patients with primary asymptomatic gout. Clin Chem 25:371–375
O'Connor G, Stocks J, Lumley JSP, Galton DJ (1987) A DNA polymorphism of the apoprotein AI-CIII-AIV gene cluster and extracoronary vascular disease. Clin Sci (in press)
Patsch JR, Gotto AM, Oliverona T, Eisenberg S (1978) Formation of HDL2 like particles during lipolysis of VLDL in vitro. Proc Natl Acad Sci USA 75:4519–4523
Price WH, Morris SW, Kitchen AH (1987) Allele frequency at five polymorphic DNA restriction enzyme sites of the apo AI-CIII-AIV gene cluster and coronary heart disease in a Scottish population. Clin Sci [Suppl 16] 72:46 (abstr)
Rees A, Stocks J, Sharpe C, Vella M, Shoulders C, Katz J, Jowett NI, Baralle FE, Galton DJ (1985a) Deoxyribonucleic acid in the apolipoprotein AI-CIII gene cluster. J Clin Invest 76:1090–1095
Rees A, Caplin JL, Jowett NI, Stocks J, Williams L, Galton DJ (1985b) DNA polymorphism in the ApoCIII and insulin gene and atherosclerosis. Atherosclerosis 58:269–275
Rees A, Stocks J, Paul H, Ohuchi Y, Galton DJ (1986) Haplotypes identified by by DNA polymorphism at the apolipoprotein AI-CIII gene locus and hypertriglyceridaemia: a study in a Japanese population. Hum Genet 72:168–171
Sharpe CR, Sidoli A, Shelley SC, Lucero MA, Shoulders CC, Baralle FE (1984) Human apolipoproteins AI, AII, CII, and CIII cDNA sequences and mRNA abundance. Nucleic Acids Res 12:3917–3932
Shoulders CC, Ball MJ, Mann JI, Baralle FE (1986) Genetic marker in apolipoprotein AI/CIII gene complex associated with hypercholesterolaemia. Lancet II:1286
Sobrinho-Simoes M (1965) A sensitive method for the measurement of uric acid using hydroxamine. J Lab Clin Med 65:665–669
Southern EM (1979) Gel electrophoresis of restriction fragments. Methods Enzymol 68:27–32
Trembath R, Thomas D, Hendra T, Yudkin J, Galton D (1987) A DNA polymorphism of the apo AI-CIII-AIV gene cluster associates with coronary heart disease in non-insulin dependent diabetes. Br Med J 294:1577–1578
Vella MA, Kessling A, Jowett N, Rees A, Stocks J, Wallis S, Galton D (1985) DNA polymorphisms flanking the apo AI and insulin genes and type III hyperlidaemia. Hum Genet 69:275–276
Warnick GR, Albers JJ (1978) A comprehensive evaluation of the Heparin-Manganese precipitation procedure for estimating HDL-cholesterol. J Lipid Res 19:65–76
Woolf B (1955) Estimating the relationship between blood group and disease. Ann Hum Genet 19:251–253
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferns, G.A.A., Lanham, J., Dieppe, P. et al. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet 78, 55–59 (1988). https://doi.org/10.1007/BF00291235
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00291235